Role of therapeutic apheresis in the treatment of pediatric kidney diseases

Pediatr Nephrol. 2022 Feb;37(2):315-328. doi: 10.1007/s00467-021-05093-w. Epub 2021 May 15.

Abstract

Therapeutic apheresis utilizes apheresis procedures in the treatment of a variety of conditions including kidney disease. Therapeutic plasma exchange (TPE) is the most common modality employed with the rationale of rapid reduction of a pathogenic substance distributed primarily in the intravascular compartment; however other techniques which adsorb such pathogenic substances or alter the immune profile have been utilized in diseases affecting native and transplanted kidneys. This article discusses the modalities and technical details of therapeutic apheresis and summarizes its role in individual diseases affecting the kidney. Complications related to pediatric apheresis procedures and specifically related to apheresis in kidney disease are also discussed. Though therapeutic apheresis modalities are employed frequently in children with kidney disease, most experiences are extrapolated from adult studies. International and national registries need to be established to elucidate the role of apheresis modalities in children with kidney disease.

Keywords: Apheresis - Pediatric - Renal diseases.

MeSH terms

  • Blood Component Removal* / adverse effects
  • Blood Component Removal* / methods
  • Child
  • Female
  • Humans
  • Kidney Diseases* / therapy
  • Male
  • Plasma Exchange / adverse effects
  • Plasma Exchange / methods
  • Registries